4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-25-038800
Chief Medical Officer acquired 115,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Daniel Chief Medical Officer | 2025-03-12 | Grant or award | +115,000 | 453,013 | D |
Loading xslF345X05/ownership.xml…